Company / EPS (Basic)
Traws Pharma, Inc. EPS (Basic) History
FY2021-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
-$35.21
FY2024
5-year range
-$35.21 / -$0.91
FY2021-FY2024
Trend
-3769.2%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
EPS (Basic) changed -3769% YoY in FY2024, a notable deviation from the 3-year average annual change of -1236%.
Based on SEC 10-K filings.
-35.21 in FY2024.
Declined from $-0.96 to $-35.21 over the past 2 years.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, eps (basic) decreased 3769.2% year-over-year.
Company context
Key Data Points
- Altman Z-Score -42.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$35.21 | -3769.2% |
| FY2023 | -$0.91 | +5.2% |
| FY2022 | -$0.96 | +55.8% |
| FY2021 | -$2.17 | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
| FY2015 | - | - |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026